Advances in Purinergic Signaling
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Biology".
Deadline for manuscript submissions: closed (15 April 2023) | Viewed by 1493
Special Issue Editor
Interests: autoimmune diseases; neurodegenerative diseases; purinergic system; inflammatory processes and oxidative stress
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Proposed in 1972, purinergic signaling is characterized by the relationship between signaling components, receptors, and specific enzymes. The purinergic system is characterized by the action of extracellular nucleotides and nucleosides that are degraded by the action of several ectonucleotidases. ATP is an intracellular energy molecule, but it can be released from various types of cells after damage. Thus, after release, it can activate receptors or be rapidly decomposed by ectonucleotidases. Purinergic signaling receptors are classified into two main groups: P1 nucleoside receptors and P2 purinoceptors. All cells have components of the purinergic system and can release nucleotides in a controlled situation. It is now established that changes in purinergic signaling are involved in the therapy of many diseases, in addition to being related to the effects of physical exercise and nutraceutical molecules on the body. This Special Issue aims to present and discuss the advancement of research and innovative therapies involving the purinergic system and diseases with a high impact on society, such as diabetes, hypertension, atherosclerosis, heart disease, cancer, and chronic kidney disease, neurological diseases, such as epilepsy, and neurodegenerative ones, such as Alzheimer's and Parkinson's diseases as well as multiple sclerosis, with the possibility of involving communicable and chronic diseases emerging.
Dr. Margarete Dulce Bagatini
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- purinergic receptors
- ectonucleotidases
- nucleotides
- nucleoside
- ATP
